Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance.
- NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_assertion description "[The interleukin-3 receptor ? chain (CD123) has been identified as a potential immunotherapeutic target because it is overexpressed in AML compared with normal hematopoietic stem cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance.
- NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_assertion evidence source_evidence_literature NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance.
- NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_assertion SIO_000772 24030378 NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance.
- NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_assertion wasDerivedFrom befree-20150227 NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance.
- NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_assertion wasGeneratedBy ECO_0000203 NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP494293.RAqrTJebi3Jy_OVaevKglw6jK2SEbqH6B6JJuJ6NF1fE8130_provenance.